Wilson Sonsini Goodrich & Rosati advised Sorriso Pharmaceuticals on the deal.Sorriso Pharmaceuticals, a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory…
Sorriso Pharmaceuticals’ $31 Million Series A Financing
